'The Most Expensive Drug Is the One That Doesn't Work'

Sep 11, 2019, 05:00 PM
Welcome to Contagion® Connect. This new podcast will bring you expert perspectives on trending infectious disease topics. 
 
In this episode, we take a dual look at the recently announced changes to antibiotic reimbursements from the Centers for Medicare and Medicaid Services. First, we’ll speak to Dr. Susan Davis, an infectious disease pharmacist, about the impact from a clinician standpoint. Then we'll talk to Larry Edwards, CEO of Tetraphase Pharmaceuticals, for an industry perspective.

A transcript of the interview is available on ContagionLive.com.

Follow Contagion® on Twitter.

Music credit: Joseph McDade